2 news items
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
ABSI
21 Mar 24
position as the Executive Vice President of BioPharmaceuticals R&D at AstraZeneca, and joins Absci as the company scales its AI-enabled portfolio
Latest Updates of Viva Biotech's Portfolio Companies
ABSI
6 Mar 24
the evolution of R&D and the success of commercialization. Recently, Viva Biotech's portfolio companies have new updates. Keep reading for more
- Prev
- 1
- Next